Exact Mass: 426.0341
Exact Mass Matches: 426.0341
Found 89 metabolites which its exact mass value is equals to given mass value 426.0341
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diflunisal glucuronide ester
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
Diflunisal glucuronide ether
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
Hydroxy-2-naphthalenylmethylphosphonic acid tris-acetoxymethyl ester
Axillarin 7-sulfate
3-[3,5-bis(trifluoromethyl)anilino]-2-(2-thienylsulfonyl)acrylonitrile
Methyl 2, 7-dichloronorpsoromate|methyl 2,7-dichloronorpsoromate
2-(3,4-Dihydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-5,7-dihydroxy-2,3-epoxy-3,4-dihydro-2H-1-benzopyran-4-one
11-(3-carboxy-3-hydroxy-propionyl)-5-hydroxy-1-oxo-1,12-dihydro-4H-pyrido[3,2-a]phenoxazine-3-carboxylic acid|alpha-hydroxy-alpha-deamino-dihydro-xanthommatin|Rhodommatin
3,4,5-trimetoxyphenil 1-O-beta-(6-sulpho)-glucopyranoside
Methyl 8-phenoxy-4-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate
5-chloro-2-[[1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonic acid
Calcium ascorbate dihydrate
D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins
Thioacetic acid S-[4-[4-(4-acetylsulfanylphenylethynyl)-phenylethynyl]-phenyl] ester
methyl N-[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonylcarbamate
(2S,3S)-2,3-BIS((4-CHLOROBENZOYL)OXY)SUCCINIC ACID
1,2,3,4,5,6-Benzenehexacarboxylicacid, 1,2,3,4,5,6-hexamethyl ester
(r)-5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1h-indole
bis(trifluoromethylsulfonyl)azanide,diethyl-(2-methoxyethyl)-methylazanium
benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate
Diethyl 2,4-diacetyl-3-(4-bromophenyl)pentanedioate
Etofamide
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AC - Dichloroacetamide derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
dipotassium [[N,N-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N,O,O,ON,ON]manganate(2-)
Afuresertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively[1][2].
1-(Thiophen-2-ylmethyl)-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine
3-O-methylfluorescein 6-phosphate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
4-Bromo-2-[3-(2-methoxyphenyl)acryloyl]phenyl 2-furoate
2-[[3-(3-Oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid
6-(2,6-Dichlorophenyl)-2-{[3-(hydroxymethyl)phenyl]amino}-8-methylpyrido[2,3-D]pyrimidin-7(8H)-one
5-(2,3-Dichlorophenyl)-N-(Pyridin-4-Ylmethyl)-3-Thiocyanatopyrazolo[1,5-A]pyrimidin-7-Amine
Mefoxin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(7-hydroxy-2-oxochromen-6-yl)oxyoxan-2-yl]methoxy]propanoic acid
8-chloro-4-(3-chloro-4-fluoroanilino)-6-(1H-imidazol-5-ylmethylamino)-3-quinolinecarbonitrile
5-Chloropyridin-3-yl 1-[(4-methylphenyl)sulfonyl]-1h-indole-5-carboxylate
7-(4-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
7-(3-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
N-(6-chloro-1,3-benzothiazol-2-yl)-2-diphenylphosphorylacetamide
Benzoic acid 4-bromo-2-[(5-methyl-2H-pyrazole-3-carbonyl)-hydrazonomethyl]-phenyl ester
2-[5-[(4-Bromophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide
2-[[2,2,2-trichloro-1-[(2,2-dimethyl-1-oxopropyl)amino]ethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester
5-(4-chlorophenyl)-3-{[(1E)-(2-hydroxy-3-nitrophenyl)methylene]amino}thieno[2,3-d]pyrimidin-4(3H)-one
2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide
3-chloro-N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
ethyl 2-[[2,2,2-trichloro-1-(2-methylpropanoylamino)ethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
(5-Hydroxy-11-methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraen-4-yl) hydrogen sulate
cefoxitin(1-)
A cephalosporin carboxylic acid anion having methoxy, 2-thienylacetamido and carbamoyloxymethyl side-groups, formed by proton loss from the carboxy group of the semisynthetic cephamycin antibiotic cefoxitin.